Document Type
Article
Publication Date
11-2-2010
Publication Title
Science Signaling
Abstract
DNA methyltransferase 1 (DNMT1) is the primary enzyme that maintains DNA methylation. We describe a previously unknown mode of regulation of DNMT1 protein stability through the coordinated action of an array of DNMT1-associated proteins. DNMT1 was destabilized by acetylation by the acetyltransferase Tip60, which triggered ubiquitination by the E3 ligase UHRF1, thereby targeting DNMT1 for proteasomal degradation. In contrast, DNMT1 was stabilized by histone deacetylase 1 (HDAC1) and the deubiquitinase HAUSP (herpes virus–associated ubiquitin-specific protease). Analysis of the abundance of DNMT1 and Tip60, as well as the association between HAUSP and DNMT1, suggested that during the cell cycle the initiation of DNMT1 degradation was coordinated with the end of DNA replication and the need for DNMT activity. In human colon cancers, the abundance of DNMT1 correlated with that of HAUSP. HAUSP knockdown rendered colon cancer cells more sensitive to killing by HDAC inhibitors both in tissue culture and in tumor xenograft models. Thus, these studies provide a mechanism-based rationale for the development of HDAC and HAUSP inhibitors for combined use in cancer therapy.
Recommended Citation
Du, Zhanwen; Song, Jing; Wang, Yong; Zhao, Yiqing; Guda, Kishore; Yang, Shuming; Kao, Hung Ying; Xu, Yan; Willis, Joseph; Markowitz, Sanford D.; Sedwick, David; Ewing, Robert M.; and Wang, Zhenghe, "DNMT1 Stability Is Regulated by Proteins Coordinating Deubiquitination and Acetylation-Driven Ubiquitination" (2010). Chemistry Faculty Publications. 186.
https://engagedscholarship.csuohio.edu/scichem_facpub/186
DOI
10.1126/scisignal.2001462
Version
Postprint
Publisher's Statement
This is the author’s version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in Science Signaling vol 3, 02 Nov 2010, DOI: 10.1126/scisignal.2001462
Volume
3
Issue
146
Comments
This research was supported by the NIH (grants R01-CA127590, R01-HG004722, and HG004722-02S1) and the V foundation (to Z.W.); R01-CA101983 (to D.S.); DK078965 and HL093269 (to H.-Y.K.); and the core facilities of the Case Comprehensive Cancer Center (P30 CA43703).